Atomoxetine
Strattera
Norepinephrine Reuptake Inhibitor
NADAC/unit
$0.4058
No Shortage
Tier 1: 138.3%
PA Req: 2.1%
8 Manufacturers
56 ANDAs
vs. brand Strattera: Generic saves up to 96% per unit
Market Intelligence
2025-02-26 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-02-26 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-02-26 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-02-26 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-02-26 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
APOTEX INCAUROBINDO PHARMA LTDDR REDDYS LABORATORIES LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT VSTRIDES PHARMA GLOBAL PTE LTDTEVA PHARMACEUTICALS USAZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.